Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
255.06
-3.44 (-1.33%)
At close: Mar 9, 2026

SHA:688506 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
-3,220403.961,005154.22
Upgrade
Short-Term Investments
-2,533---
Upgrade
Cash & Short-Term Investments
6,1575,753403.961,005154.22
Upgrade
Cash Growth
7.02%1324.16%-59.79%551.49%-36.99%
Upgrade
Accounts Receivable
-138.71137.85267.92134.95
Upgrade
Other Receivables
-34.333.95.142.95
Upgrade
Receivables
-173.05141.75273.06137.9
Upgrade
Inventory
-162.19140.91101.3382.33
Upgrade
Other Current Assets
-218.8789.247.2249.36
Upgrade
Total Current Assets
-6,307775.821,426423.81
Upgrade
Property, Plant & Equipment
-573.09534.79420.26404.98
Upgrade
Other Intangible Assets
-26.682829.5331.16
Upgrade
Long-Term Deferred Tax Assets
-179.276.1883.2365.8
Upgrade
Long-Term Deferred Charges
-18.41.821.791.16
Upgrade
Other Long-Term Assets
-32.798.530.2824.54
Upgrade
Total Assets
-7,1371,4251,991951.46
Upgrade
Accounts Payable
-219.25160.17128.8545.96
Upgrade
Accrued Expenses
-437.25257.88244.81139.81
Upgrade
Short-Term Debt
-595.5275.12155.13161.23
Upgrade
Current Portion of Long-Term Debt
-235.28174.3730.470.02
Upgrade
Current Portion of Leases
-20.1946.1368.8224.23
Upgrade
Current Income Taxes Payable
-14.130.014.961.54
Upgrade
Current Unearned Revenue
-356.138.6717.4210.78
Upgrade
Other Current Liabilities
-102.21131.4886.7487.75
Upgrade
Total Current Liabilities
-1,9801,054737.2471.32
Upgrade
Long-Term Debt
-1,189183.92239.9650
Upgrade
Long-Term Leases
-28.138.6552.9551.42
Upgrade
Long-Term Unearned Revenue
-42.2715.6313.2931.04
Upgrade
Long-Term Deferred Tax Liabilities
-1.94-0.08-
Upgrade
Other Long-Term Liabilities
-9.7311.1914.0515.81
Upgrade
Total Liabilities
-3,2511,2731,058619.61
Upgrade
Common Stock
-401401401360.9
Upgrade
Additional Paid-In Capital
-885.84858.69858.5514.17
Upgrade
Retained Earnings
-2,599-1,109-328.45-45.98
Upgrade
Comprehensive Income & Other
-0.531.132.792.76
Upgrade
Total Common Equity
7,1713,886151.87933.89331.85
Upgrade
Shareholders' Equity
7,1713,886151.87933.89331.85
Upgrade
Total Liabilities & Equity
-7,1371,4251,991951.46
Upgrade
Total Debt
3,7712,069688.19547.33286.91
Upgrade
Net Cash (Debt)
2,3863,685-284.23457.41-132.69
Upgrade
Net Cash Growth
-35.24%----
Upgrade
Net Cash Per Share
5.779.19-0.711.26-0.37
Upgrade
Filing Date Shares Outstanding
412.87401401401360.9
Upgrade
Total Common Shares Outstanding
412.87401401401360.9
Upgrade
Working Capital
-4,327-278.01689.14-47.51
Upgrade
Book Value Per Share
17.379.690.382.330.92
Upgrade
Tangible Book Value
7,1423,859123.88904.36300.69
Upgrade
Tangible Book Value Per Share
17.309.620.312.260.83
Upgrade
Buildings
-325.3304.56302.23300.82
Upgrade
Machinery
-640.12554.25439.83419.75
Upgrade
Construction In Progress
-35.5181.3767.2118.18
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.